Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
NCT02731911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 202
Last updated 2019-01-23
Summary
This prospective study will assess Ozurdex in the treatment of Diabetic Macular Oedema in clinical practice.
Conditions
- Diabetic Macular Oedema
Interventions
- DRUG
-
dexamethasone intravitreal implant
Ozurdex® treatment for diabetic macular oedema as per standard of care in clinical practice.
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Dr. George Labib · Allergan
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-29
- Primary Completion
- 2018-10-22
- Completion
- 2018-10-22
Countries
- Australia
Study Locations
More Related Trials
-
Ozurdex in Suboptimal Diabetic Macular Edema Patients
NCT04856397 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®
NCT02181530 ·Status: COMPLETED
-
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
NCT01571232 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion
NCT01903720 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
NCT01571557 ·Status: COMPLETED
-
A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China
NCT06548568 ·Status: ACTIVE_NOT_RECRUITING
-
A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
NCT01445626 ·Status: COMPLETED
-
Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)
NCT03889444 ·Status: COMPLETED
-
Diabetic Macular Edema Treated With Ozurdex (DMEO)
NCT01951066 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
NCT01618266 ·Status: COMPLETED
-
Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema
NCT02399657 ·Status: UNKNOWN ·Phase: PHASE4
-
Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
NCT01411696 ·Status: COMPLETED
-
Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX)
NCT04116398 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
NCT01449682 ·Status: COMPLETED ·Phase: PHASE3
-
Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)
NCT01613716 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery
NCT01788475 ·Status: TERMINATED ·Phase: NA
-
The Effects of Intravitreal Ozurdex Implant in DME
NCT03475407 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema
NCT01698788 ·Status: COMPLETED ·Phase: NA
-
Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone
NCT01892163 ·Status: COMPLETED ·Phase: PHASE3
-
Ozurdex for Retinal Vein Occlusion Study (ORVO Study)
NCT01790685 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections
NCT06894017 ·Status: RECRUITING
-
Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema
NCT01698749 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
NCT01410201 ·Status: TERMINATED ·Phase: NA
-
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
NCT05978622 ·Status: ACTIVE_NOT_RECRUITING
-
Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
NCT02684084 ·Status: TERMINATED ·Phase: PHASE4